Received May 19, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | nt357 | IM / LA |
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: pt stated she is a physician and noticed redness/swelling/rash at injection site approx 7 days after administration, tried benadryl, and called her physician friend who is a dermatologist to obtain a topical cream. pt states other than the injection site, overall she feels fine. pharmacist asked pt to call pharmacy is further symptoms/side effects develope or worsen , Other Vaccines: VaccineTypeBrand: shingrix; Manufacturer: glaxosmith; LotNumber: nt357; Route: im; BodySite: left deltoid; Dose: 00; VaxDate: 04/28/2026
miconazole nitrate, tramadol